Suchergebnisse - "Ferenci, Tamás"

PubPharm (37)

1

Myocardial infarction without obstructive coronary artery disease (MINOCA) - prevalence and prognosis

enthalten in: Orvosi hetilap | 2019

von Jánosi, A. | Ferenci, T. | Kőszegi, Z. | +8

2

Does The Type of Ossicular Chain Lesion Affect Outcomes in Chronic Suppurative Otitis Media Without Cholesteatoma?

enthalten in: The journal of international advanced otology | 2019

von Horvath, T. | Lukacs, D. | Horvath, B. | +2

3

One-year persistence of fixed-dose combinations of angiotensin-converting enzyme inhibitor and calcium channel blocker in hypertensive patients

enthalten in: Orvosi hetilap | 2019

von Simonyi, G. | Ferenci, T. | Finta, E. | +4

4

One-year persistence of patients already treated with oral anticoagulants for atrial fibrillation

enthalten in: Orvosi hetilap | 2019

von Simonyi, G. | Ferenci, T. | Finta, E. | +2

5

Can Google Trends data improve forecasting of Lyme disease incidence?

enthalten in: Zoonoses and public health | 2019

von Kapitány-Fövény, M. | Ferenci, T. | Sulyok, Z. | +4

6

Does Gender Have Prognostic Value Among Patients with Myocardial Infarction? Analysis of the Data from the Hungarian Myocardial Infarction Registry

enthalten in: Journal of women's health (2002) | 2018

von Jánosi, A. | Ferenci, T. | Ofner, P. | +10

7

Effect of smoking on survival after myocardial infarction - smoker's paradox in Hungary?

enthalten in: Orvosi hetilap | 2018

von El-Meouch, N. | Ferenci, T. | Jánosi, A.

8

The significance of ECG recorded at hospitalization in determining the prognosis of patients treated with myocardial infarction

enthalten in: Orvosi hetilap | 2018

von Jánosi, A. | Ofner, P. | Tomcsányi, J. | +5

9

The Use of Complementary and Alternative Medicine Is Less Frequent in Patients with Inflammatory Bowel Disease Than in Patients with Other Chronic Gastrointestinal Disorders

enthalten in: Gastroenterology research and practice | 2018

von Fábián, A. | Rutka, M. | Ferenci, T. | +9

10

Absolute risk reduction may depend on the duration of the follow-up

enthalten in: Expert review of clinical pharmacology | 2017

von Ferenci, T.

CommentOn: Expert Rev Clin Pharmacol. 2015 Mar;8(2):201-10. - PMID 25672965